HIGHLIGHTS
- who: Yahia Alghazwani and collaborators from the Department of Pharmacology, College of Pharmacy, King Khalid University, Abha, Saudi Arabia have published the research: The Combined Anti-Tumor Efficacy of Bioactive Hydroxyapatite Nanoparticles Loaded with Altretamine, in the Journal: Pharmaceutics 2023, 302 of 28/08/2021
- what: In this study the combined anti-tumor efficacy of nanoparticles (HA-NPs) loaded with altretamine (ALT) was evaluated. This investigation proposes the usage of altretamine (ALT)-loaded HA-NPs for synergistic anticancer action based on the above explanation.
- how: The investigation clearly shows that the formulation prepared . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.